A randomized, double-blind, parallel-group and active controlled clinical study to assess the efficacy and safety of FDC of Bisoprolol and Cilnidipine tablet versus FDC of Metoprolol Succinate ER and Cilnidipine in treating Hypertension associated with coronary artery disease

Authors
Category Primary study
Registry of TrialsClinical Trials Registry - India
Year 2024
This article has no abstract
Epistemonikos ID: fc98748d2c2a826c119a6d5d03a6344da97e7b27
First added on: Apr 09, 2025